RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% is indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents. The only available FDA-approved treatment for the reversal of pharmacologically-induced mydriasis.
RYZUMVI™ is a sterile, clear, and colorless topical ophthalmic solution and comes in a translucent, low-density polyethylene, single-patient-use vial.
Contents: 6 pouches containing 5 single patient use vials each
- Reverse dilation with just 1-2 drops
- Shipped in insulated packaging
- 6 pouches containing 5 vials each
- Store refrigerated at 2 C to 8 C
- Protect from freezing
*Cold Ship Fee $20.00*
Specifications and More Data
| Rx\OTC |
Rx (You must have a state license to purchase this product) |
| NDC: |
83368-075-30 |
| Manufacturer |
OcuPhire
|
